Evidence map›Paper›PMID 30667376›Full record

ArticleThe Journal of clinical investigation2019

A nonhuman primate model of inherited retinal disease.

Ala Moshiri, Rui Chen, Soohyun Kim, R Alan Harris, Yumei Li, Muthuswamy Raveendran, Sarah Davis, Qingnan Liang, Ori Pomerantz, Jun Wang and 12 more

Open access · hybridAbstract readVideo-Audio Media
In one paragraph

Article in The Journal of clinical investigation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Rhesus macaques with anProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Article
  10. AFrontiers in cell and developmental biology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Ala MoshiriDepartment of Ophthalmology & Vision Science, School of Medicine, UC Davis, Sacramento, California, USA.
Rui ChenHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Soohyun KimDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
R Alan HarrisHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Yumei LiHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Muthuswamy RaveendranHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Sarah DavisCalifornia National Primate Research Center, Davis, California, USA.
Qingnan LiangDepartment of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, USA.
Ori PomerantzCalifornia National Primate Research Center, Davis, California, USA.
Jun WangHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Laura GarzelCalifornia National Primate Research Center, Davis, California, USA.
Ashley CameronCalifornia National Primate Research Center, Davis, California, USA.
Glenn YiuDepartment of Ophthalmology & Vision Science, School of Medicine, UC Davis, Sacramento, California, USA.
J Timothy StoutDepartment of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, USA.
Yijun HuangEyeKor Inc., Madison, Wisconsin, USA.
Christopher J MurphyDepartment of Ophthalmology & Vision Science, School of Medicine, UC Davis, Sacramento, California, USA.
Jeffrey RobertsDepartment of Surgical and Radiological Sciences, School of Veterinary Medicine, University of California-Davis, Davis, California, USA.
Kota N GopalakrishnaDepartment of Molecular Physiology and Biophysics, and.
Kimberly BoydDepartment of Molecular Physiology and Biophysics, and.
Nikolai O ArtemyevDepartment of Molecular Physiology and Biophysics, and.
Jeffrey RogersHuman Genome Sequencing Center and Department of Molecular and Human Genetics, and.
Sara M ThomasyDepartment of Ophthalmology & Vision Science, School of Medicine, UC Davis, Sacramento, California, USA.
University of California, Davis · USBaylor College of Medicine · USInstitute of Molecular Biology and Biophysics · RUUniversity of Wisconsin–Madison · USUniversity of Iowa · US

Funding

National Institute on Aging (NIA) ColonyP51OD011107 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Simon J. Atkinson · 2012 to 2026
$191.5M
VISION RESEARCH CORE GRANTP30EY012576 · NEI · UNIVERSITY OF CALIFORNIA DAVIS · PI MARIE E BURNS · 1999 to 2026
$18.9M
VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
REGULATION OF ROD CYCLIC GMP PHOSPHODIESTERASER01EY010843 · NEI · UNIVERSITY OF IOWA · PI Nikolai O Artemyev · 1995 to 2026
$8.9M
Novel Model Systems for the Study of Cone Disorders and Other Heritable Retinal DiseasesU24EY029904 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI, ROGERS, JEFFREY A. · 2018 to 2023
$7.7M
Large Scale Sequencing Variation in Rhesue Macaques - HIV Vaccine SupplementR24OD011173 · OD · BAYLOR COLLEGE OF MEDICINE · PI ROGERS, JEFFREY A. · 2012 to 2017
$3.7M
Animal Models of Ocular DiseaseR01EY026045 · NEI · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI, ROGERS, JEFFREY A. · 2016 to 2021
$3.3M
The Role of ARAP1 in Retinal Photoreceptor HomeostasisK08EY027463 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MOSHIRI, ALA · 2017 to 2021
$1.0M
Engineering the Corneal Wound Bed to Promote HealingK08EY021142 · NEI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI THOMASY, SARA MICHELLE · 2011 to 2015
$879k
High Throughput Genomic Sequencer at BCM Core FacilityS10OD023469 · OD · BAYLOR COLLEGE OF MEDICINE · PI CHEN, RUI · 2017 to 2017
$600k
Large-Scale Discovery of Functional Genetic Variation in Rhesus MacaquesR24RR032329 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI ROGERS, JEFFREY A. · 2011 to 2011
$549k
NCRR NIH HHS R24 RR032329NEI NIH HHS K08 EY021142NEI NIH HHS K08 EY027463NEI NIH HHS P30 EY002520NEI NIH HHS P30 EY012576NEI NIH HHS R01 EY010843NEI NIH HHS R01 EY026045NEI NIH HHS U24 EY029904NIH HHS P51 OD011107NIH HHS R24 OD011173NIH HHS S10 OD023469
6 · The paper itself

Abstract

Inherited retinal degenerations are a common cause of untreatable blindness worldwide, with retinitis pigmentosa and cone dystrophy affecting approximately 1 in 3500 and 1 in 10,000 individuals, respectively. A major limitation to the development of effective therapies is the lack of availability of animal models that fully replicate the human condition. Particularly for cone disorders, rodent, canine, and feline models with no true macula have substantive limitations. By contrast, the cone-rich macula of a nonhuman primate (NHP) closely mirrors that of the human retina. Consequently, well-defined NHP models of heritable retinal diseases, particularly cone disorders that are predictive of human conditions, are necessary to more efficiently advance new therapies for patients. We have identified 4 related NHPs at the California National Primate Research Center with visual impairment and findings from clinical ophthalmic examination, advanced retinal imaging, and electrophysiology consistent with achromatopsia. Genetic sequencing confirmed a homozygous R565Q missense mutation in the catalytic domain of PDE6C, a cone-specific phototransduction enzyme associated with achromatopsia in humans. Biochemical studies demonstrate that the mutant mRNA is translated into a stable protein that displays normal cellular localization but is unable to hydrolyze cyclic GMP (cGMP). This NHP model of a cone disorder will not only serve as a therapeutic testing ground for achromatopsia gene replacement, but also for optimization of gene editing in the macula and of cone cell replacement in general.

Indexed as

Cone DystrophyCyclic Nucleotide Phosphodiesterases, Type 6Disease Models, AnimalEye ProteinsMutation, MissenseRetinitis PigmentosaAmino Acid SubstitutionAnimalsColor Vision DefectsFemaleHEK293 CellsHumansMacaca mulattaMaleCyclic Nucleotide Phosphodiesterases, Type 6Eye ProteinsGenetic diseasesOphthalmology

Identifiers

PMID30667376
PMCPMC6355306
OpenAlexW2912647544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.